| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.24 | 0.0005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |